Your browser doesn't support javascript.
loading
Azithromycin and Roxithromycin define a new family of "senolytic" drugs that target senescent human fibroblasts.
Ozsvari, Bela; Nuttall, John R; Sotgia, Federica; Lisanti, Michael P.
Affiliation
  • Ozsvari B; Translational Medicine, University of Salford, Greater Manchester, United Kingdom.
  • Nuttall JR; Translational Medicine, University of Salford, Greater Manchester, United Kingdom.
  • Sotgia F; Translational Medicine, University of Salford, Greater Manchester, United Kingdom.
  • Lisanti MP; Translational Medicine, University of Salford, Greater Manchester, United Kingdom.
Aging (Albany NY) ; 10(11): 3294-3307, 2018 11 14.
Article in En | MEDLINE | ID: mdl-30428454
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Roxithromycin / Cellular Senescence / Azithromycin / Fibroblasts Type of study: Prognostic_studies Limits: Humans Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2018 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Roxithromycin / Cellular Senescence / Azithromycin / Fibroblasts Type of study: Prognostic_studies Limits: Humans Language: En Journal: Aging (Albany NY) Journal subject: GERIATRIA Year: 2018 Document type: Article Affiliation country: United kingdom